| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |